These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2905)

  • 41. Distributions of several agents useful in imaging myocardial infarcts.
    Bonte FJ; Parkey RW; Graham KD; Moore JG
    J Nucl Med; 1975 Feb; 16(2):132-5. PubMed ID: 162951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical comparison of the kinetics of 99mTc pyrophosphate and 99mTc methylene diphosphonate (author's transl)].
    Casara D; Cimitan M; Zorat P; Calzavara F
    Radiol Med; 1979; 65(1-2):67-70. PubMed ID: 223200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
    Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
    J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Incorporation of radioactive calcium and technetium pyrophosphate in to bones].
    Markt B; Bergmann G; Raab W; Willvonseder R
    Acta Med Austriaca; 1977; 4(4-9):144-8. PubMed ID: 205073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 99mTc bone scanning agents--I. Influence of experimental conditions on the formation and gel chromatography of 99mTc(Sn)pyrophosphate complexes.
    Kroesbergen J; Gelsema WJ; De Ligny CL
    Int J Nucl Med Biol; 1985; 12(2):83-8. PubMed ID: 2995268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Investigations on the bone uptake of 99mTc-pyrophosphate, 99mTc-poly-phosphate and radio-strontium (author's transl)].
    Büll U; Frey KW
    Fortschr Geb Rontgenstr Nuklearmed; 1973 Nov; 119(5):569-77. PubMed ID: 4360989
    [No Abstract]   [Full Text] [Related]  

  • 47. Mechanism of localization of 99mTc-labeled pyrophosphate and tetracycline in infarcted myocardium.
    Dewanjee MK; Kahn PC
    J Nucl Med; 1976 Jul; 17(7):639-46. PubMed ID: 178842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone accumulation of 99mTc-labeled leucocytes.
    Bagwe BA; Sharma SM
    J Nucl Med; 1976 Apr; 17(4):313-6. PubMed ID: 1255260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [99m Tc Sn-pyrophosphate complex as a bone gammography agent in children].
    Avila Ramírez E; Goldberg de Liverant J; Larrondo JJ
    Bol Med Hosp Infant Mex; 1974; 31(6):1115-24. PubMed ID: 4373020
    [No Abstract]   [Full Text] [Related]  

  • 50. Kinetics of 99mTc-labeled pyrophosphate and polyphosphate in man.
    Krishnamurthy GT; Huebotter RJ; Walsh CF; Taylor JR; Kehr MD; Tubis M; Blahd WH
    J Nucl Med; 1975 Feb; 16(2):109-15. PubMed ID: 162949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of the metabolic acitivity of bone in rheumatoid arthritis.
    Rosenspire KC; Kennedy AC; Steinbach J; Blau M; Green FA
    J Rheumatol; 1980; 7(4):469-73. PubMed ID: 6252321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mean ionic charge on two components of technetium pyrophosphate prepared using stannous chloride.
    Russell CD; Bischoff PG
    Int J Appl Radiat Isot; 1984 Sep; 35(9):859-63. PubMed ID: 6090320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Complexes 99mTc-Sn-DTPA, 99mTc-Fe-ascorbic acid, and 99mTc-Sn-calcium-gluconogalactogluconate in the diagnosis of renal function and morphology (author's transl)].
    Licińska I; Graban W; Jakubowski W; Krasucki T; Lachnik E; Wiza J; Zulczyk W; Smoliński S; Zielińska B
    Pol Przegl Radiol Med Nukl; 1977; 41(1):57-61. PubMed ID: 859758
    [No Abstract]   [Full Text] [Related]  

  • 54. Whole-body autoradiography of 99Tcm-labelled pyrophosphate and related compounds in young rats.
    Rohlin M; Hammarström L
    Acta Radiol Ther Phys Biol; 1976 Feb; 15(1):71-80. PubMed ID: 179283
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Radiochemical purity and stability of Tc-99m-pyrophosphate].
    Vucina J
    Med Pregl; 2000; 53(9-10):502-5. PubMed ID: 11320732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pyrophosphate retention by previously irradiated renal tissue.
    Lutrin CL; Goris ML
    Radiology; 1979 Oct; 133(1):207-9. PubMed ID: 224416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro interaction between 99Tcm-labeled pyrophosphate, 32P-labeled pyrophosphate and rat tissues.
    Rohlin M; Larsson A; Hammarström L
    Eur J Nucl Med; 1978; 3(4):249-55. PubMed ID: 31287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of adjunctive drugs to alter uptake of 99mTc-Sn-pyrophosphate by myocardial lesions and bone.
    Carr EA; Carroll M; Montes M
    Life Sci; 1978 Apr 3-17; 22(13-15):1261-74. PubMed ID: 207941
    [No Abstract]   [Full Text] [Related]  

  • 59. Alteration of body distribution of 99mTc-pyrophosphate by radiographic contrast material.
    Crawford JA; Gumerman LW
    Clin Nucl Med; 1978 Aug; 3(8):305-7. PubMed ID: 212243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of experimental conditions on the formation of various 99mTc(Sn)EHDP complexes.
    van den Brand JA; Das HA; Dekker BG; de Ligny L
    Int J Appl Radiat Isot; 1982 Jan; 33(1):39-45. PubMed ID: 6800964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.